5 Recruiting Metastatic Malignant Solid Neoplasm Phase 2 Clinical Trials

Active phase 2 studies for metastatic malignant solid neoplasm enrolling across the USA. Verify eligibility and contact site coordinators.

All Metastatic Malignant Solid Neoplasm studies

Phase 2 Studies for Metastatic Malignant Solid Neoplasm

🔵 Active, Not Recruiting Phase2

Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial

📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2

Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors

📍 M D Anderson Cancer Center — Houston, Texas

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2

Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid Tumors

📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2

Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 Expression

📍 M D Anderson Cancer Center — Houston, Texas

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2

Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer

📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona

View Study & Checklist ➔